FI57939C - Foerfarande foer framstaellning av 1,3-dihydro-2h-1,4-benzodiazepin-2-onderivat - Google Patents
Foerfarande foer framstaellning av 1,3-dihydro-2h-1,4-benzodiazepin-2-onderivat Download PDFInfo
- Publication number
- FI57939C FI57939C FI2613/73A FI261373A FI57939C FI 57939 C FI57939 C FI 57939C FI 2613/73 A FI2613/73 A FI 2613/73A FI 261373 A FI261373 A FI 261373A FI 57939 C FI57939 C FI 57939C
- Authority
- FI
- Finland
- Prior art keywords
- ammonia
- dihydro
- phenyl
- benzodiazepin
- mixture
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 38
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 202
- 229910021529 ammonia Inorganic materials 0.000 claims description 101
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 79
- 239000011541 reaction mixture Substances 0.000 claims description 46
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 38
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000003960 organic solvent Substances 0.000 claims description 16
- 239000000460 chlorine Substances 0.000 claims description 15
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 239000007858 starting material Substances 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- UDLAUVFRZXIQJS-UHFFFAOYSA-N 1,3-dihydro-1,4-benzodiazepin-2-one Chemical class N1C(=O)CN=CC2=CC=CC=C21 UDLAUVFRZXIQJS-UHFFFAOYSA-N 0.000 claims 1
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 96
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 239000000203 mixture Substances 0.000 description 41
- 229960004011 methenamine Drugs 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 238000009835 boiling Methods 0.000 description 30
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 238000010992 reflux Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 15
- AKPLHCDWDRPJGD-UHFFFAOYSA-N nordazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1 AKPLHCDWDRPJGD-UHFFFAOYSA-N 0.000 description 14
- 230000007935 neutral effect Effects 0.000 description 13
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 13
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- HDXLZRWEZZFDKA-UHFFFAOYSA-N n-(2-benzoyl-4-chlorophenyl)-2-chloroacetamide Chemical compound ClCC(=O)NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 HDXLZRWEZZFDKA-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000012429 reaction media Substances 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- RGGLEJFUEMKQSH-UHFFFAOYSA-N 1,4-benzodiazepin-2-one Chemical compound O=C1C=NC=C2C=CC=CC2=N1 RGGLEJFUEMKQSH-UHFFFAOYSA-N 0.000 description 3
- IVUAAOBNUNMJQC-UHFFFAOYSA-N 5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC=CC=C2NC(=O)CN=C1C1=CC=CC=C1 IVUAAOBNUNMJQC-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- -1 for example Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- KNGIGRDYBQPXKQ-UHFFFAOYSA-N 5-(2-fluorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1F KNGIGRDYBQPXKQ-UHFFFAOYSA-N 0.000 description 2
- DNADLWKZQXEWFL-UHFFFAOYSA-N 7-chloro-5-phenyl-1,3-dihydro-1-benzazepin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)CC=C1C1=CC=CC=C1 DNADLWKZQXEWFL-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- UVCOILFBWYKHHB-UHFFFAOYSA-N desalkylflurazepam Chemical compound FC1=CC=CC=C1C1=NCC(=O)NC2=CC=C(Cl)C=C12 UVCOILFBWYKHHB-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- DSAWUUVGNZAARH-UHFFFAOYSA-N n-(2-benzoyl-4-chlorophenyl)-2-chloro-n-methylacetamide Chemical compound ClCC(=O)N(C)C1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 DSAWUUVGNZAARH-UHFFFAOYSA-N 0.000 description 2
- HIMNRRQRDQNAEN-UHFFFAOYSA-N n-(2-benzoylphenyl)-2-chloroacetamide Chemical compound ClCC(=O)NC1=CC=CC=C1C(=O)C1=CC=CC=C1 HIMNRRQRDQNAEN-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical class CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- FJZLANUAMGHEGO-UHFFFAOYSA-N 1,3-dihydro-1-benzazepin-2-one Chemical class N1C(=O)CC=CC2=CC=CC=C21 FJZLANUAMGHEGO-UHFFFAOYSA-N 0.000 description 1
- XSTMFEOLMKEEMU-UHFFFAOYSA-N 2-bromo-n-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide Chemical compound [O-][N+](=O)C1=CC=C(NC(=O)CBr)C(C(=O)C=2C(=CC=CC=2)Cl)=C1 XSTMFEOLMKEEMU-UHFFFAOYSA-N 0.000 description 1
- UCBHRCPNMDOUMV-UHFFFAOYSA-N 2-chloro-n-(3-nitrophenyl)acetamide Chemical compound [O-][N+](=O)C1=CC=CC(NC(=O)CCl)=C1 UCBHRCPNMDOUMV-UHFFFAOYSA-N 0.000 description 1
- JXGJTLQYJCMHKX-UHFFFAOYSA-N 2-chloro-n-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide Chemical compound FC1=CC=CC=C1C(=O)C1=CC(Cl)=CC=C1NC(=O)CCl JXGJTLQYJCMHKX-UHFFFAOYSA-N 0.000 description 1
- GUSMEDHRIBVVJG-UHFFFAOYSA-N 5-(2-chlorophenyl)-7-nitro-1,5-dihydro-1,4-benzodiazepin-2-one Chemical compound ClC1=C(C=CC=C1)C1N=CC(NC2=C1C=C(C=C2)[N+](=O)[O-])=O GUSMEDHRIBVVJG-UHFFFAOYSA-N 0.000 description 1
- WZKJLWIDCSCTNV-UHFFFAOYSA-N 7-nitro-5-phenyl-1,3-dihydro-1-benzazepin-2-one Chemical compound [O-][N+](=O)C1=CC=C2NC(=O)CC=C(C3=CC=CC=C3)C2=C1 WZKJLWIDCSCTNV-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- CHLGVPLOUIFPHE-UHFFFAOYSA-N C1=CC=C(C(=C1)C(=O)C(C(=O)NC2=CC=C(C=C2)Cl)Br)Cl Chemical compound C1=CC=C(C(=C1)C(=O)C(C(=O)NC2=CC=C(C=C2)Cl)Br)Cl CHLGVPLOUIFPHE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 101100032401 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pyr-4 gene Proteins 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- CHIFCDOIPRCHCF-UHFFFAOYSA-N delorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl CHIFCDOIPRCHCF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- LYISZEZBKBGONS-UHFFFAOYSA-N n-[4-bromo-2-(pyridine-2-carbonyl)phenyl]-2-chloroacetamide Chemical compound ClCC(=O)NC1=CC=C(Br)C=C1C(=O)C1=CC=CC=N1 LYISZEZBKBGONS-UHFFFAOYSA-N 0.000 description 1
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28221772A | 1972-08-21 | 1972-08-21 | |
| US28221772 | 1972-08-21 | ||
| US35981473A | 1973-05-14 | 1973-05-14 | |
| US35981473 | 1973-05-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI57939B FI57939B (fi) | 1980-07-31 |
| FI57939C true FI57939C (fi) | 1980-11-10 |
Family
ID=26961312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI2613/73A FI57939C (fi) | 1972-08-21 | 1973-08-21 | Foerfarande foer framstaellning av 1,3-dihydro-2h-1,4-benzodiazepin-2-onderivat |
Country Status (24)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5334792A (en) * | 1976-09-13 | 1978-03-31 | Scherico Ltd | Production of 1*44 benzodiazepines and 1*44 benzodiazepinee22ones |
| RU2120441C1 (ru) * | 1996-10-18 | 1998-10-20 | Олег Иванович Лукашов | Способ получения 7-бром-1,3-дигидро-5-/2-хлорфенил/-2н-1,4-бензидиазепин-2-она, промежуточное соединение 5-бром-2-/2-хлорацетамидо/-2'-хлорбензофенон |
| RU2150467C1 (ru) * | 1998-01-06 | 2000-06-10 | Петрунин Александр Иванович | Способ получения 1,3-дигидро-7-нитро-5-фенил-2h-1,4-бензодиазепин-2-она (нитразепама) (варианты) |
| CN113149915B (zh) * | 2021-03-01 | 2024-03-15 | 中国科学院成都有机化学有限公司 | 一种合成氯硝西泮化合物的方法 |
| CN116023342B (zh) * | 2021-10-26 | 2024-06-25 | 江苏昱林生物科技有限公司 | 一种高纯度氯硝西泮的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1136709B (de) * | 1959-12-10 | 1962-09-20 | Hoffmann La Roche | Verfahren zur Herstellung von 2-Oxo-1, 2-dihydro-1, 4-benzodiazepinen |
| CH537393A (de) * | 1969-10-16 | 1973-05-31 | Hoffmann La Roche | Verfahren zur Herstellung von 1,4-Benzodiazepin-derivaten |
| BE785962A (fr) * | 1971-07-08 | 1973-01-08 | Hoffmann La Roche | Procede pour la preparation de derives de benzodiazepine |
-
1973
- 1973-08-02 CH CH1121873A patent/CH578544A5/xx not_active IP Right Cessation
- 1973-08-08 DE DE19732340159 patent/DE2340159A1/de active Granted
- 1973-08-10 IL IL42947A patent/IL42947A/en unknown
- 1973-08-13 AU AU59180/73A patent/AU472777B2/en not_active Expired
- 1973-08-14 YU YU02198/73A patent/YU219873A/xx unknown
- 1973-08-15 IE IE1409/73A patent/IE38091B1/xx unknown
- 1973-08-15 PH PH14926A patent/PH13640A/en unknown
- 1973-08-16 HU HUHO1604A patent/HU170153B/hu not_active IP Right Cessation
- 1973-08-16 AR AR249597A patent/AR198108A1/es active
- 1973-08-17 AT AT720773A patent/AT341527B/de not_active IP Right Cessation
- 1973-08-20 SE SE7311319A patent/SE408302B/xx unknown
- 1973-08-20 CA CA179,143A patent/CA1012535A/en not_active Expired
- 1973-08-20 PL PL1973164759A patent/PL99162B1/pl unknown
- 1973-08-20 JP JP48093220A patent/JPS5911589B2/ja not_active Expired
- 1973-08-20 LU LU68269A patent/LU68269A1/xx unknown
- 1973-08-20 NO NO3285/73A patent/NO139481C/no unknown
- 1973-08-20 ES ES418014A patent/ES418014A1/es not_active Expired
- 1973-08-20 GB GB3921873A patent/GB1392681A/en not_active Expired
- 1973-08-20 SU SU1959095A patent/SU550980A3/ru active
- 1973-08-20 DD DD172980A patent/DD107040A5/xx unknown
- 1973-08-20 DK DK457773A patent/DK155326C/da not_active IP Right Cessation
- 1973-08-21 NL NLAANVRAGE7311507,A patent/NL179582C/xx not_active IP Right Cessation
- 1973-08-21 FI FI2613/73A patent/FI57939C/fi active
- 1973-08-21 FR FR7330353A patent/FR2197003B1/fr not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3299053A (en) | Novel 1-and/or 4-substituted alkyl 5-aromatic-3h-1, 4-benzodiazepines and benzodiazepine-2-ones | |
| US3398159A (en) | Aminophenyl heterocyclic ketones | |
| SE440504B (sv) | Mellanprodukt for framstellning av imidazo (1,5-a)(1,4)diazepiner | |
| FI57939C (fi) | Foerfarande foer framstaellning av 1,3-dihydro-2h-1,4-benzodiazepin-2-onderivat | |
| CA1157855A (en) | Benzodiazepine derivatives | |
| US3546212A (en) | Oxidation of benzodiazepines with ruthenium tetroxide | |
| US3442946A (en) | 2-aminomercapto- and 2-aminoalkylcaptobenzophenone oximes | |
| CH497436A (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| US3198789A (en) | Certain j-amino-s-phenyl-l,j-dihydro-zh- l,x-benzxraazepin-z-qnx c compounds | |
| US3290292A (en) | 1, 1'-lower alkylene-bis | |
| US3144439A (en) | Process for production of benzo- | |
| FI56385C (fi) | Metod foer framstaellning av bl a som lugnande laekemedel anvaendbara s-triazolo(1,5-a)(1,4)bensodiazepinderivat | |
| FI57938B (fi) | Foerfarande foer framstaellning av 2-hydrazino-5-fenyl-3h-1,4-benzodiazepinderivat | |
| US4335042A (en) | Process to produce imidazobenzodiazepine intermediates | |
| US3691157A (en) | Preparation of 7-substituted-1-(2-diethylaminoethyl)-5-(2-halophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-ones | |
| DE1795372C3 (de) | 10.01.68 Japan 1501-68 Verfahren zur Herstellung von 5-(o-Halogenphenyl)-7-halogen-1,3-dihydro-2H-1,4-benzodiazepin-2-onen und 2-Aminomethylindole und ihre Salze | |
| US3501474A (en) | Certain 1,3,4,5-tetrahydro-2h-1,4-benzodiazepin-2-ones | |
| DE2540586A1 (de) | Verfahren zur herstellung von heterocyclischen verbindungen | |
| CS196231B2 (cs) | Způsob přípravy nových derivátů benzodiazepinu | |
| FI71152C (fi) | Nytt foerfarande foer framstaellning av 1,2-dihydro-1h-imidazo/1,2-a/ /1,4/bensodiazepin-1-on-derivat och deras salter | |
| CA1067492A (en) | Diazepine compounds and method for their production | |
| SU466660A3 (ru) | Способ получени производных бензодиазепина | |
| DE1813240B2 (de) | Verfahren zur Herstellung von 1,3.-Dihydro-2H-1,4-benzodiazepin-2-on-derivaten | |
| DE2204484A1 (de) | Verfahren zur herstellung von 1,4benzodiazepinen | |
| CH622253A5 (en) | Process for the preparation of 1,4-benzodiazepines |